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Yellow (y) encodes a protein which is closely similar to major royal jelly proteins produced by bees.
However, the function of y remains largely unknown. Metabolomic proﬁling was carried out on
third instar Oregon R (OR) and yellow (y) Drosophila melanogaster larvae. Phenylalanine, tyrosine
and DOPA were all elevated in y as might be expected since the mutation blocks melanin biosynthe-
sis. The most consistent effects were related to lysine metabolism, with the lysine metabolite sac-
charopine being much higher in y. In addition, lysine acetate was elevated, and the levels of
methyl lysines were lower, in y than in OR.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction In previous papers we have looked at the effects of a known ge-Yellow ( y) was one of the ﬁrst Drosophila mutants discovered
[1] and encodes a multifunctional protein with close similarity to
the major royal jelly protein of honeybees. According to the Dro-
sophila gene expression database, FlyAtlas.org [2], y is speciﬁcally
expressed only in larval salivary glands, suggesting a secretory or
digestive function. Royal jelly is secreted from analogous glands
in the heads of honeybee workers, suggesting a conserved role
for y. It has been proposed that in the honeybee y proteins may
regulate development epigenetically by promoting DNA methyla-
tion [3]. Y is also extensively expressed in the pupal cuticle, where
it plays a major role in melanisation [4]; and expression in the CNS
is required for normal male reproductive behaviour [5–7]. So y ap-
pears to play multiple roles, although its exact biochemical modes
of action are still unknown.
It has been proposed that Yellow is a structural protein and that
it is involved in forming cross-links with the dopamine derivative
indole-5,6-quinone during melanisation [5]. Another theory is that
it acts downstream of dihydroxyphenylalanine (DOPA) in the for-
mation of melanin; there is some sequence homology between
the y protein and dopachrome conversion enzyme (DCE) [8].al Societies. Published by Elsevier
osophila lysine ketoglutarate
E, dopachrome conversion
henylalanine
son).netic lesion rosy on the global metabolite proﬁle in Drosophila and
found effects on metabolites remote from those directly affected
by the lesion [9] and also attempted to explain an unknown genetic
lesion [10]. We report here the application of metabolomics in or-
der to elucidate the effects of the y gene.
2. Materials and methods
2.1. Chemicals and solvents
HPLC grade acetonitrile, formic and water were obtained from
Fisher Scientiﬁc, UK. All other chemicals were from Sigma–Aldrich,
UK.
2.2. Fly larvae
Laboratory grown wild-type Oregon R strain of Drosophila mel-
anogaster was used as the control for the y1 amorphic mutant
(Bloomington Stock Centre, Indiana, #169). Larvae were raised on
standard medium on a 12:12 h L:D cycle, at 23 C, and at 55% rel-
ative humidity. For metabolomic analysis, feeding third-instar lar-
vae (before they stop feeding and climb away from their food)
were selected. Ice cold methanol/chloroform/water (3:1:1, 250
ll) was used in the sample quenching and extraction method.
Ten larvae from both genders were collected from the food for each
biological replicate. First the larvae were rinsed in phosphate buf-B.V. Open access under CC BY-NC-ND license.
218 M.A. Bratty et al. / FEBS Open Bio 2 (2012) 217–221fer saline (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 and 1.47
mM KH2PO4; adjusted to a ﬁnal pH of 7.4), blotted dry, then
homogenised in the solvent mixture, followed by 10 s of sonica-
tion. The homogenate was then centrifuged for 10 min at 4 C.
The supernatant was collected and stored at 80 C until analysis.
A total of four biological replicates containing 10 mixed male and
female larvae was collected for each strain at each time point.
2.3. DNA/RNA hydrolysis
DNA/RNA was extracted from 100 larvae for each biological rep-
licate using the phenol–chloroform extraction method [11]. A total
of four biological replicates were prepared for both Oregon R and
the ymutant. Brieﬂy, the DNA extraction procedure was as follows:
whole larvae were ground in a 1.5 ml microcentrifuge tube using a
hand pestle and subsequently sonicated brieﬂy using a Microson
Ultrasonic cell disruptor (Misonix Inc, USA) in 400 ll buffer A
(100 mM Tris–HCl (pH 7.5), 100 mM EDTA, 100 mM NaCl, 0.5%
SDS). After incubation at 65 C for 30 min, 800 ll of LiCl/KAc mix-
ture (1 part 5 M KAc:2.5 parts 6 M LiCl) was added. The samples
were spun for 15 min at room temperature (RT) at maximum speed
in a table-top microcentrifuge. Floating curd was removed using a
pipette tip and 1 ml of supernatant was taken into a new tube.
Then, 600 ll of isopropanol was added and the sample was mixed
using a pipette. Another round of centrifugation was performed at
RT for 15 min. The supernatant was discarded and the pellet was
washed with 70% ethanol and dried for 15 min at RT. Dried pellet
was re-suspended in 100 ll of nuclease-free water. DNA/RNA was
quantiﬁed using a NanoVue plus spectrophotometer (GE Life Sci-
ences, UK).
For DNA/RNA hydrolysis, a method was adapted from Kriaucio-
nis et al. [12]. Brieﬂy, 100 lg of DNA/RNA were incubated in the
hydrolysis solution (100 mM NaCl, 20 mM MgCl2, 20 mM Tris pH
7.9, 1 U/ll Benzonase™ endonuclease, 600 mU/ml phosphodiester-
ase I, 80 U/ml alkaline phosphatase, 36 lg/ml EHNA-hydrochlo-
ride, 2.7 mM desferoxamine). Hydrolysed DNA/RNA was ﬁltered
using an Amicon microcon 10 kDa cut-off centrifugal ﬁlter unit
(Millipore UK Ltd.). The hydrolysate was used for LC–MS analysis
after diluting (1:4) with acetonitrile.
2.4. Nuclear protein isolation
For histone analysis, the nuclear protein fraction was extracted
using NE-PER nuclear extraction reagent kit (Thermo Scientiﬁc,
UK). Brieﬂy, 50 larvae were washed in phosphate buffer saline
(PBS) 3 times. Using a pipette, all the residual PBS was removed
and the larvae were homogenized at 4 C in ice-cold CER I buffer
(including 1:100 protease inhibitor cocktail from Sigma–Aldrich,
UK). The rest of the extraction was performed according to the
manufacturer protocol. Finally the nuclear fraction was collected
and protein quantity was measured using a Bradford calorimetric
protein assay kit (BIO-RAD, UK). A total of 80 lg of nuclear protein
was used for the hydrolysis as follows. The protein was mixed with
160 ll of 6M HCl in a vial. The vial was sealed and heated in an
oven at 145 C for 4 h. The mixture was cooled and 160 ll of 3
M sodium bicarbonate was added. Then 0.4 ml of acetonitrile
was added to a protein crash plate (Biotage Ltd, Sweden) followed
by 0.2 ml of the acid hydrolysate. Salts were allowed to precipitate
for 10 min and then the sample was ﬁltered. The ﬁltrate was used
for LC–MS analysis.
2.5. LC–MS method
LC–MS data were acquired using an LTQ Orbitrap instrument
(Thermo Scientiﬁc, UK) set at 30,000 resolution. Sample analysis
was carried out under both positive and negative ion modes. Themass scanning range was m/z 50–1200, the capillary temperature
was 200 C and the sheath and auxiliary gas ﬂow rates were 30
and 10 arbitrary units respectively. The LC–MS system (controlled
by Xcalibur version 2.0, Thermo) was run in binary gradient mode.
Solvent A was 0.1% v/v formic acid in HPLC grade water and solvent
B was 0.1% v/v formic acid in acetonitrile. Analysis was carried out
on a ZICHILIC column (150  4.6 mm, 5 lm particle size, HiChrom
Ltd., UK) ﬁtted with a guard column. A ﬂow rate of 300 ll/min was
used and the injection volume was 10 ll, the gradient used was as
follows: 90% B at (0 min) – 50% B at (16 min) – 20% B at (18 min) –
20% B at (28 min) – 90% B at (36 min). Samples were kept in a vial
tray which was set at a constant temperature of 3 C. The injection
volume was 25 ll.
The instrument was calibrated according to the manufacturer’s
instructions just before commencing the experiment, and was
internally calibrated by lock masses (positive ion mode m/z
83.06037 and m/z 195.08625, due to acetonitrile dimer and caf-
feine respectively; and negative ion mode 91.00368 due to formic
acid dimer). Runs were carried out in negative ion mode using the
conditions above after tuning in the negative ion mode and the
assigning appropriate lock mass. Runs were also carried out on
an Orbitrap Exactive instrument ﬁtted with a HCD cell using the
same mass spectrometry parameters and chromatographic condi-
tions with a HCD cell energy of 20 eV.
2.6. Data processing
Data ﬁles were processed using Sieve 1.3 (Thermo, UK). The
parameters used in Sieve were: time range 4–30 min, mass range
75–700 amu, frame width 0.02 amu and Rt width 2.5 min. The out-
put from Sieve was transferred into Sieve Extractor, an Excel
spreadsheet and an in-house macro written in Visual Basic, and
used to search against a mass list of 35,000 compounds taken from
the KEGG, Metlin, Human Metabolome and Lipid Maps databases.
A 3 ppm window was set for assignment of elemental composition
and often there was only one chemically sensible elemental com-
position within this window. Matching against the database con-
ﬁrmed this where only one hit was returned or if more than one
hit was returned then the additional hits were isomers. Sieve soft-
ware measures P-values using a two-tailed Student’s t-test. We
have found good agreement for selected compounds between
manually calculated values and the values returned by the soft-
ware. Proﬁling was based on for samples of larvae taken at three
time points during two months ( n = 4 at each sampling point). Re-
peat sampling gives more conﬁdence in the stability of differences
over time. It is not possible to combine results from separate sam-
pling points because of variations in instrument sensitivity and
chromatography; relatively small variations in chromatographic
retention time make peak alignment difﬁcult.
3. Results and discussion
Table 1 summarises some putatively identiﬁed unusual metab-
olites present in the larvae and also metabolites where there is a
marked variation between y and OR. Novel metabolites were indi-
vidually curated, requiring a mass accuracy within 1.5 ppm of the
proposed structure, and with no sensible elemental composition
within 3 ppm of the assigned elemental composition based on
the elements C, N, H, O, P and S. All the metabolites listed in Table 1
were also checked manually to conﬁrm that they were not isotope
peaks, adducts, fragments or dimers of more intense ions. Table S1
(supplementary) shows the MS2 data for some the more unusual
metabolites which helps to conﬁrm their structures.
y is a visible mutant of melanisation, and appears to lack homol-
ogy to known enzymes in the tyrosinase/dopa pathways, but in-
Table 1
List of unusual metabolites and metabolites displaying signiﬁcant differences (n = 4 at each sampling point) between y and OR larvae. Four extracts from 10 y and 10 OR mixed
male and female larvae were prepared on 3 occasions over a two month time period. ‘‘Ratio’’ is of y: OR peak area.
Compounds MH+/M Rt Replicate 1 Replicate 2 Replicate 3
min Ratio P value Ratio P value Ratio P value
Melanin biosynthesis
Dihydroxyindole 150.0545 8.0 3.30 1.80E02 4.15 1.90E02 2.27 5.50E02
Phenylalanine 166.0864 12.4 2.21 7.10E06 2.18 3.90E03 1.99 3.10E04
Tyrosine 182.081 14.9 1.73 5.90E03 2.12 9.30E02 3.32 1.70E04
Dopamine acetate 196.097 7.5 0.52 1.70E03 2.30 1.80E01 0.523 4.00E01
DOPA 198.0761 17.3 2.67 3.00E02 3.29 1.30E03 3.229 5.20E03
Glycyl-dopa 255.0978 17.1 1.34 2.10E01 1.96 1.40E01 1.98 5.80E02
Dihydroxy indole GSH 455.1231 17.2 0.90 8.20E01 ND 0.64 3.30E01
Lysine metabolism
Lysine 147.1129 23.4 2.23 1.20E02 2.07 3.70E02 1.62 3.90E02
Methyllysine 161.1287 23.0 0.62 7.70E04 0.72 4.30E02 0.83 2.70E01
2-Aminoadipate 162.0763 16.1 2.00 2.20E02 2.28 2.90E02 1.38 1.30E01
Carnitine 162.1127 15.4 0.60 2.30E08 0.60 6.90E04 0.81 1.50E02
Dimethyl lysine 175.1442 23.1 0.41 3.00E05 0.39 1.80E04 0.56 2.40E02
Lysine acetate 189.1236 16.4 6.19 4.70E03 4.50 5.00E03 3.16 4.70E05
Trimethyl lysine 189.1599 23.8 0.36 3.30E03 0.45 2.00E03 0.61 1.30E01
Diaminopimelate 191.1028 16.6 0.66 1.30E02 0.51 7.90E03 0.77 2.80E03
Aspartyl lysine 262.1397 21.5 0.01 5.80E05 0.05 1.20E01 0.064 7.50E03
Saccharopine 277.1395 20.8 8.20 1.80E02 9.50 5.80E03 5.093 3.70E02
Fructosyl lysine 309.1658 23.8 0.47 3.70E03 0.78 3.30E02 0.87 5.00E01
Chitin biosynthesis
N-acetylglycosamine 222.0975 13.5 0.10 3.20E02 0.50 5.80E01 0.198 2.00E01
N-acetylglycosamine isomer 222.0975 15.0 0.06 3.00E02 0.54 6.7 E01 0.045 2.10E01
Glycosamine phosphate isomer 260.0532 19.9 1.55 4.20E03 0.95 6.30E01 0.374 2.30E01
Glycosamine phosphate isomer 260.0532 22.2 0.14 6.50E04 ND ND 0.024 4.70E03
Neuraminic acid 268.1027 20.0 1.71 5.70E04 3.44 4.40E04 2.003 2.00E03
Glycosamine acetate phosphate 302.0638 19.8 0.35 1.20E02 0.66 4.60E02 0.58 2.30E03
Cytidine monophosphate 324.0594 20.4 2.40 3.20E02 7.77 9.80E03 3.51 4.20E02
UDP Glc NAc 608.0886 25.8 1.16 1.70E01 2.01 4.50E02 1.812 6.50E03
Tryptophan metabolism
Kynurenic acid 190.05 8.9 2.52 4.80E03 2.29 4.10E03 3.289 2.00E04
Xanthurenic acid 206.0449 10.6 2.31 8.90E03 2.68 5.90E02 7.904 2.90E03
Hydroxytryptophan 221.0923 12.8 0.35 4.50E02 0.12 4.60E03 0.26 6.30E02
Hydroxykynurenine 225.087 14.2 0.40 3.70E06 0.35 8.70E04 0.43 1.10E02
GSH oxidative stress
Methionine S-oxide 166.0534 18.3 6.29 3.40E03 3.78 1.80E02 3.26 2.00E04
Cystathione 223.0749 21.8 2.13 5.00E02 2.71 2.90E02 1.81 1.80E01
GSH 308.0912 16.3 0.05 9.50E06 0.00 3.60E01 0.01 3.30E01
GSH-cysteine 427.0954 21.0 0.43 1.10E02 0.41 2.60E01 0.34 2.20E01
GSSG 613.1594 20.5 0.52 7.10E02 0.48 2.10E01 0.26 1.70E01
Methylation
Methionine 150.0584 13.9 2.52 2.00E03 1.47 9.60E02 1.70 2.90E02
S-adenosylmethionine 399.1448 24.6 2.25 5.20E03 2.13 1.50E02 2.263 1.70E03
Purine metabolism
Guanine 152.0544 13.9 2.41 4.10E03 1.39 1.60E01 1.50 6.20E02
Sepiapterin 238.0936 10.3 0.03 2.90E03 0.06 1.90E02 0.246 1.90E01
Biopterin 238.0938 13.2 0.63 1.20E04 0.56 1.70E02 0.311 2.20E01
Dihydrobiopterin 240.1093 13.9 0.25 6.50E04 0.18 6.90E04 0.263 2.00E02
Methyladenosine 282.1185 19.4 2.70 2.80E03 10.70 3.80E03 1.02 8.80E01
Methylguanosine 298.1146 11.1 0.43 3.90E04 0.25 1.60E03 0.552 5.20E02
Misc. metabolites
Threonine 120.0657 17.4 1.96 7.50E03 2.43 1.10E02 1.95 8.20E03
Asparagine 133.0609 18.5 0.49 1.90E02 0.45 8.30E03 0.34 2.00E03
Glutamine 147.0765 18.2 0.60 1.70E02 0.55 7.60E03 0.71 1.50E04
Histidine 156.0769 22.6 0.63 1.00E04 0.65 1.40E02 0.61 4.20E02
Choline phosphate 184.0734 22.4 0.32 2.00E03 0.30 9.60E06 0.41 9.50E06
Dimethylarginine 203.1391 22.5 0.22 2.30E02 ND - 0.61 3.10 E02
Cytidine 244.093 17.8 1.66 1.80E02 2.59 6.70E03 0.485 1.40E02
Uridine 245.077 10.8 1.17 2.90E01 2.17 6.80E02 0.674 2.60E03
Arginine phosphate 255.0853 22.8 0.56 7.00E04 0.35 1.40E04 0.326 3.20E03
Tyrosine phosphate 262.0475 20.7 1.06 3.50E01 1.48 1.60E02 0.264 3.60E02
Arginosuccinate 291.1301 22.0 0.38 1.20E03 0.45 1.60E02 0.115 7.30E03
Riboﬂavin 377.1454 9.5 3.23 1.10E03 2.65 2.10E02 2.842 1.40E04
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Yellow-f and Yellow-f2 [8]. As might be expected there is thus a
marked effect of the absence of y protein on metabolites in the
pathway of eumelanin biosynthesis (Fig. 1) with phenylalanine,
tyrosine, DOPA and dihydroxyindole (DHI) consistently accumulat-
ing in all three batches of y larvae analysed. A widespread theory ofthe action of y is that it governs dopachrome conversion. However,
the presence of DHI in y, which is an immediate precursor of
eumelanin, indicates that it is not simply lack of a precursor which
blocks eumelanin biosynthesis. The only enzymatic step between
DHI and eumelanin is catalysed by tyrosinase which is used twice
in the pathway leading to DHI. A clue to the fate of DHI not used in
Fig. 1. Impact of y mutation on eumelanin biosynthesis with known Drosophila
enzymes indicated, and fold changes for metabolites for y versus OR (from Table 1)
shown in arrows.
Fig. 3. Impact of y mutation on lysine catabolism with known Drosophila enzymes
indicated, and fold changes for metabolites for y versus OR (from Table 1) shown in
arrows. Note that there are no enzymes present in drosophila capable of
synthesizing lysine; as in other higher animals, lysine is an essential amino acid.
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dant peaks which correspond to the glutathione adducts of DHI
(Fig. 2); the multiple peaks are due to reaction at more than one
position in the ring system. The levels of DHI-GSH do not differ be-
tween y and OR. Apart from the eumelanin biosynthesis pathway
there are number of other metabolic pathways that are strikingly
affected in y.
The most metabolites within a single pathway that are affected
by the mutation are related to lysine metabolism (Fig. 3). A major
metabolite of lysine in the larvae is fructosyl lysine which has only
been reported as a non-enzymatic glycation product deriving from
the reaction between lysine residues within proteins and glucose
[13]. Lysine is consistently elevated in y and the lysine metabolite
saccharopine is elevated between 5 and 10 times compared to OR.
The elevated levels of saccharopine are interesting in view of the
recent ﬁnding that the ketoglutarate reductase (dLKR)/saccharo-
pine dehydrogenase (SDH), the enzyme responsible for saccharo-
pine formation, has been found to suppress ecdysone-mediated
cell death [14]. dLKR/SDH suppresses the activity of ecdysone by
binding to histones H3 and H4 thus inhibiting arginine methyla-
tion within the histone tails. In y, lysine acetate levels are elevated
>x3 and, when compared with OR, and methyl-, dimethyl- and tri-
methyllysine are two to three times lower than in OR. Both acetyl-
lysine and methylated lysines are derived from turnover of his-
tones and provide two strategies controlling chromatin remodel-
ling and thus gene transcription. Acetylation of lysine removesFig. 2. Extracted ion trace showing the putatively identiﬁed GSH conjugates of DHI.the electrostatic interaction between the lysine residues in histone
and the phosphate backbone of DNA allowing access of transcrip-
tional enzymes [15]. y larvae also contain elevated levels of amino-
adipate which is the next step in the lysine degradation pathway.
Tryptophan metabolism via the kynurenine pathway is also af-
fected with hydroxykynurenine levels being lower in y and levels
of the downstream metabolites in this pathway kynurenic acid
and xanthurenic acid being elevated. Both kynurenic and xanthu-
renic acids are produced by the enzyme L-kynurenine:2-oxoglutar-
ate aminotransferase (KOA). The gene coding for this enzyme is
orthologous with 2-aminoadipate transaminase which is responsi-
ble for the formation of oxoadipate from aminoadipate in the ly-
sine degradation pathway. Thus increased levels of kynurenic
acid and xanthurenic acid may be linked to the increase in lysine
degradation products.
Several metabolic changes observed in y larvae were consistent
with variation in histone modiﬁcation. Histone proteins are stea-
dily turned over [16] and might be expected to contribute modiﬁed
methyllysines and dimethylarginine to the metabolome. In addi-
tion, methionine and S-adenosyl methionine accumulate in y as if
they were being underutilised. This suggests some differences in
the regulation of methylation between OR and y. In order to deter-
mine whether or not y is directly involved in controlling the level
of methylation of histone proteins, histones were isolated from
OR and y larvae and subjected to a simple acid hydrolysis.
Although the isolated proteins were rich in methylated lysine res-
idues, particularly trimethyl lysine, there were no signiﬁcant dif-
ferences in the degree of methylation of histones from y and OR.
In addition to methylated lysines there was an abundance of
dimethylarginine present in the hydrolysate from the histones
but there was no signiﬁcant difference between dimethyl arginine
in hydrolysates from y and OR histones. Table S2 (supplementary)
summarises the data obtained for methyllysines and arginine in OR
and y normalised to the mean areas for the peaks for lysine or argi-
nine in the hydrolysate.
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volved in epigenetic modiﬁcation of DNA via methylation [17]
and it was decided to examine DNA isolated from OR and y.
DNA/RNA was isolated from OR and y larvae and enzymatically di-
gested to yield free DNA/RNA bases and then analysed by LCMS. All
of the bases detected were derived from RNA and contained ribose
rather than deoxyribose and no modiﬁed DNA bases were de-
tected. It was possible to see methylated bases to a level of ca
0.1% of the non-methylated bases (Fig. S1 supplementary), there
was no signiﬁcant difference in the levels of methylated RNA bases
between OR and y. Table S3 (supplementary) summarises the data
obtained for DNA and RNA bases isolated by hydrolysis.
Table 1 also shows a number of changes in the levels of chitin
precursors and the current study supports the idea that y behaves
like a regulatory hormone or cofactor affecting a variety of meta-
bolic pathways. Effects on chitin biosynthesis point to y possibly
mediating its effects through regulation of ecdysone activity which
has been found to regulate genes involved in chitin biosynthesis
[18]. It may be that the regulation of chitin biosynthesis is most
signiﬁcant with regard to the function of y since formation of the
correct chitin structure may be necessary for proper functioning
of melanin production.
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